Abstract:The lymphatic network remodeling may guide tumor metastasis in a sentinel lymph node (SLN). Although tumor-derived exosomes have been demonstrated to modify the microenvironment in adjacent organs and initiate a premetastatic niche, their influence on the lymphatic network in SLNs has not been explained. Here, we show that CT26 cell exosomes (Exo) promote the proliferation of lymphatic endothelial cells and the formation of lymphatic network in SLN, facilitating the SLN metastasis of colorectal cancer (CRC). U… Show more
“…Limitations of this work include the omission of lymphatic flow rates as a considered variable despite it being widely hypothesized that they are substantially changed in disease contexts ( Habenicht et al., 2017 ; Hinson et al., 2017 ; Ji, 2017 ; Otto et al., 2014 ; Stacker et al., 2014 ; Sun et al., 2019 ). Given that the dependencies of WSS on SCS height and volumetric flow rate are first versus second order, respectively, we focused instead on how small changes with respect to SCS height could influence cell interactions within the SCS under the influence of fluid flow.…”
Summary
A lymph node sinus-on-a-chip adhesion microfluidic platform that recapitulates the hydrodynamic microenvironment of the lymph node subcapsular sinus was engineered. This device was used to interrogate the effects of lymph node remodeling on cellular adhesion in fluid flow relevant to lymphatic metastasis. Wall shear stress levels analytically estimated and modeled after quiescent and diseased/inflamed lymph nodes were experimentally recapitulated using a flow-based microfluidic perfusion system to assess the effects of physiological flow fields on human metastatic cancer cell adhesion. Results suggest that both altered fluid flow profiles and presentation of adhesive ligands, which are predicted to manifest within the lymph node subcapsular sinus as a result of inflammation-induced remodeling, and the presence of lymph-borne monocytic cells may synergistically contribute to the dynamic extent of cell adhesion in flow relevant to lymph node invasion by cancer and monocytic immune cells during lymphatic metastasis.
“…Limitations of this work include the omission of lymphatic flow rates as a considered variable despite it being widely hypothesized that they are substantially changed in disease contexts ( Habenicht et al., 2017 ; Hinson et al., 2017 ; Ji, 2017 ; Otto et al., 2014 ; Stacker et al., 2014 ; Sun et al., 2019 ). Given that the dependencies of WSS on SCS height and volumetric flow rate are first versus second order, respectively, we focused instead on how small changes with respect to SCS height could influence cell interactions within the SCS under the influence of fluid flow.…”
Summary
A lymph node sinus-on-a-chip adhesion microfluidic platform that recapitulates the hydrodynamic microenvironment of the lymph node subcapsular sinus was engineered. This device was used to interrogate the effects of lymph node remodeling on cellular adhesion in fluid flow relevant to lymphatic metastasis. Wall shear stress levels analytically estimated and modeled after quiescent and diseased/inflamed lymph nodes were experimentally recapitulated using a flow-based microfluidic perfusion system to assess the effects of physiological flow fields on human metastatic cancer cell adhesion. Results suggest that both altered fluid flow profiles and presentation of adhesive ligands, which are predicted to manifest within the lymph node subcapsular sinus as a result of inflammation-induced remodeling, and the presence of lymph-borne monocytic cells may synergistically contribute to the dynamic extent of cell adhesion in flow relevant to lymph node invasion by cancer and monocytic immune cells during lymphatic metastasis.
“…45 In the same year, Sun et al reported that colon cancer-cell derived exosomes containing IRF-2 are taken up by the macrophages and induce VEGFC production, which then promotes lymph node metastasis through lymphatic endothelial cell proliferation and lymphatic vessel remodeling. 46…”
Section: Role Of Exosomes In the Enlargement Of Cancer Tissue With Anmentioning
Exosomes are a subset of extracellular vesicles and their size is approximately 100 nm in diameter. They are surrounded by a lipid bilayer membrane and secreted from almost all of cells. Exosomes are generated within the endocytic system as ILV (intraluminal membrane vesicle) and secreted during the fusion of MVB (multivesicular body) with the cell membrane. Recently it has been reported that exosomes modulate cell-cell communication contributing to the maintenance of tissue homeostasis by molecules including exosomes. Moreover, exosomes released from cancer cells are involved in cancer progression. Thus, data regarding the role of the exosomes in malignant cancer will lead to development of novel diagnostic and therapeutic methods.
“…Furthermore, tumor cell dissemination is guided by the lymphatic network. IRF-2 in exosomes derived from colon cancer lines promotes the proliferation of lymphatic endothelial cells and the formation of the lymphatic network in the sentinel lymph node, increasing the frequency of F4/80+ macrophages and promoting Vascular Endothelial Growth Factor C (VEGFC) secretion [63]. Similarly, miR-221-3p, CXCR4 or podopladin have been related to lymphangiogenesis in other tumors [100,101,102].…”
Section: Cross-talk Between Tumor and Microenvironmental Cells By mentioning
confidence: 99%
“…Dotted line represents separation between primary tumor and distal metastasis. References are shown in brackets [38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63]. Created with BioRender.com.…”
The molecular profile of liquid biopsies is emerging as an alternative to tissue biopsies in the clinical management of malignant diseases. In colorectal cancer, significant liquid biopsy-based biomarkers have demonstrated an ability to discriminate between asymptomatic cancer patients and healthy controls. Furthermore, this non-invasive approach appears to provide relevant information regarding the stratification of tumors with different prognoses and the monitoring of treatment responses. This review focuses on the tumor microenvironment components which are detected in blood samples of colorectal cancer patients and might represent potential biomarkers. Exosomes released by tumor and stromal cells play a major role in the modulation of cancer progression in the primary tumor microenvironment and in the formation of an inflammatory pre-metastatic niche. Stromal cells-derived exosomes are involved in driving mechanisms that promote tumor growth, migration, metastasis, and drug resistance, therefore representing substantial signaling mediators in the tumor-stroma interaction. Besides, recent findings of specifically packaged exosome cargo in Cancer-Associated Fibroblasts of colorectal cancer patients identify novel exosomal biomarkers with potential clinical applicability. Furthermore, additional different signals emitted from the tumor microenvironment and also detectable in the blood, such as soluble factors and non-tumoral circulating cells, arise as novel promising biomarkers for cancer diagnosis, prognosis, and treatment response prediction. The therapeutic potential of these factors is still limited, and studies are in their infancy. However, innovative strategies aiming at the inhibition of tumor progression by systemic exosome depletion, exosome-mediated circulating tumor cell capturing, and exosome-drug delivery systems are currently being studied and may provide considerable advantages in the near future.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.